MNMT yields 52631.58% · PFE yields 6.13%● Live data
📍 MNMT pulled ahead of the other in Year 1
Combined, MNMT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MNMT + PFE for your $10,000?
Motivating the Masses, Inc. provides professional development and coaching services to small businesses and entrepreneurs in the United States. It operates through two segments, Business and Personal. The company offers personal and business coaching programs through a package of books and DVDs; and training and development programs through local and national seminars, on-site employee training, public and private speaking engagements, and customized life-coaching programs. Its services include Global Leadership Program that offers group coaching services; Executive Coaching services; Business Academy training programs for entrepreneurs to grow their brand; Keynotes/Speaking services at industry events and at private gatherings; Speak And Write to Make Millions, a live training program, which teaches attendees how to speak powerfully and to write best sellers; and Speakers Vault, a comprehensive on-line training program for speakers. The company's services also comprise Breakthrough the Retreat, an intensive program for executives and entrepreneurs ready; Abundance Now, a 12-part online course; Transformational Coaching services for personal development; and Motivating the Teen Spirit, an advanced life skills training for teens and their parents, as well as online modules, such as 28 Days To Results and No Matter What. Motivating the Masses, Inc. was founded in 1998 and is headquartered in Carlsbad, California.
Full MNMT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.